Migraine Studies

ALL Memory Studies Migraine Studies Multiple Sclerosis Studies Parkinson’s Studies Epilepsy Studies

  • Allergan

    UbreIvy

    UbreIvy is an oral medication made for immediate treatment of migraines.

    Status: Completed

    FDA Approved

    Details

  • PROMISE

    Eptinezumab

    Eptinezumab (ALD403) is a CGRP antagonist for the prophylaxis of frequent episodic migraines.

    Status: Completed

    FDA Approved

    Details

  • TRIUMPH

    Emgality

    Emgality (galcanezumab) is a preventive treatment for migraines.

    Status: Completed

    FDA Approved

    Details